microBiomics Project

The microBiomics project focuses on the study of the microbiota and its relationship with the development and treatment of diseases.

Recent studies indicate that microbial communities play a very important role in human health. These microorganisms, collectively referred to as microbiota, coexist in virtually every cavity of the human body and on its surface, and play an important role not only in the pathophysiology of different diseases, but also in the response of patients to drug treatments.

In this context, the multidisciplinary consortium microBiomics has been launched, coordinated by the Cima University of Navarra, and funded by the Government of Navarra in its call for Strategic R&D Projects 2021 within the SIBERIA III challenge.

The consortium is made up of essential agents in the biosanitary and industrial field of Navarra: two hospital centers, responsible for clinical care and capable of identifying healthcare challenges (Clínica Universidad de Navarra and Complejo Hospitalario de Navarra); five research centers, generators of knowledge and the development and implementation of new experimental approaches, both in research and clinical care (Cima, Navarrabiomed, CIMA LAB Diagnostics, CIN, ADItech), and two biotechnology companies and research organizations with preferential dedication to industry, experts in the generation and analysis of results, and in industrial valorization (NUCAPS, CNTA). 

The microBiomics project is funded by the Government of Navarra within its 2021 call for strategic R&D projects.

Funder: